Article Details
Retrieved on: 2023-01-07 04:57:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Aims to create investigational mRNA-based conditionally activated therapies using Moderna's mRNA technologies and CytomX's Probody therapeutic ...
Article found on: www.contractpharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here